Ms4a6d Mouse (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MS4A6D mRNA CTD PMID:36331819 Ms4a6d Mouse 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of MS4A6D mRNA CTD PMID:26682919 Ms4a6d Mouse 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of MS4A6D mRNA CTD PMID:22206623 Ms4a6d Mouse 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of MS4A6D mRNA CTD PMID:17942748 Ms4a6d Mouse 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MS4A6D mRNA CTD PMID:17942748 Ms4a6d Mouse 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of MS4A6D mRNA CTD PMID:19484750 Ms4a6d Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MS4A6D mRNA CTD PMID:17942748 Ms4a6d Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MS4A6D mRNA CTD PMID:21570461 and PMID:26377647 Ms4a6d Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MS4A6D mRNA CTD PMID:23238561 Ms4a6d Mouse 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression EXP 6480464 2 more ... CTD PMID:38648751 Ms4a6d Mouse 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of MS4A6D mRNA CTD PMID:19191707 Ms4a6d Mouse aldehydo-D-glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MS4A6D mRNA CTD PMID:37567420 Ms4a6d Mouse arsane decreases expression EXP 6480464 Arsenic results in decreased expression of MS4A6D mRNA CTD PMID:19654921 Ms4a6d Mouse arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of MS4A6D mRNA CTD PMID:19654921 Ms4a6d Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of MS4A6D mRNA CTD PMID:22228805 and PMID:23735875 Ms4a6d Mouse carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Ms4a6d Mouse chlordecone decreases expression EXP 6480464 Chlordecone results in decreased expression of MS4A6D mRNA CTD PMID:33711761 Ms4a6d Mouse chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of MS4A6D mRNA CTD PMID:29980752 Ms4a6d Mouse choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MS4A6D mRNA CTD PMID:20938992 Ms4a6d Mouse cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of MS4A6D mRNA CTD PMID:19770486 Ms4a6d Mouse D-glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MS4A6D mRNA CTD PMID:37567420 Ms4a6d Mouse dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MS4A6D mRNA CTD PMID:30529165 Ms4a6d Mouse doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of MS4A6D mRNA CTD PMID:36227756 Ms4a6d Mouse folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MS4A6D mRNA CTD PMID:20938992 Ms4a6d Mouse fructose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MS4A6D mRNA CTD PMID:37567420 Ms4a6d Mouse genistein increases expression EXP 6480464 Genistein results in increased expression of MS4A6D mRNA CTD PMID:32186404 Ms4a6d Mouse glucose multiple interactions EXP 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of MS4A6D mRNA CTD PMID:37567420 Ms4a6d Mouse GW 4064 increases expression EXP 6480464 GW 4064 results in increased expression of MS4A6D mRNA CTD PMID:26655953 Ms4a6d Mouse isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of MS4A6D mRNA CTD PMID:20003209 Ms4a6d Mouse L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MS4A6D mRNA CTD PMID:20938992 Ms4a6d Mouse lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of MS4A6D mRNA CTD PMID:27339419 Ms4a6d Mouse ozone increases expression EXP 6480464 Ozone results in increased expression of MS4A6D mRNA CTD PMID:21543283 Ms4a6d Mouse ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MS4A6D mRNA more ... CTD PMID:25658374 and PMID:34911549 Ms4a6d Mouse paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of MS4A6D mRNA CTD PMID:17562736 Ms4a6d Mouse pentachlorophenol increases expression EXP 6480464 Pentachlorophenol results in increased expression of MS4A6D mRNA CTD PMID:23892564 Ms4a6d Mouse perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of MS4A6D mRNA CTD PMID:37995155 Ms4a6d Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MS4A6D mRNA CTD PMID:36331819 Ms4a6d Mouse pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of MS4A6D mRNA CTD PMID:22698814 Ms4a6d Mouse silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of MS4A6D mRNA CTD PMID:23221170 and PMID:29341224 Ms4a6d Mouse sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of MS4A6D mRNA CTD PMID:36209798 Ms4a6d Mouse tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MS4A6D mRNA CTD PMID:27339419 and PMID:31919559 Ms4a6d Mouse titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of MS4A6D mRNA CTD PMID:23557971 and PMID:27760801 Ms4a6d Mouse tremolite asbestos increases expression EXP 6480464 tremolite results in increased expression of MS4A6D mRNA CTD PMID:29279043